April 29, 2010
Hypertensive Rat Genome Sequence Expected To Uncover Genetic Basis Of Human Hypertension
Chronic high blood pressure, also known as hypertension, is a serious health risk factor that afflicts more than 25% of all adults worldwide, but the molecular basis of the disease remains poorly understood. In a study published online today in Genome Research, scientists have sequenced the genome of the spontaneously hypertensive rat, building a rich catalog of genetic variants that will help researchers to understand causes of the disease in humans.
The spontaneously hypertensive rat (SHR) strain is the most widely studied animal model of human hypertension. Research on this strain has identified many genomic regions that likely harbor genetic variants that are responsible for the hypertension phenotype, however without a complete sequence of the hypertensive rat genome, it has been difficult to resolve many of these genomic changes and explore their molecular consequences.
The group expected that the genome sequence would reveal mutations disrupting a number of genes in the SHR strain, however the number of mutated genes they found was quite surprising - 788 genes are mutated in SHR compared to the reference genome, including 60 that are deleted altogether. "So many major differences in protein sequence were unexpected because of the previous belief that differences in a small number of genes and proteins would be responsible for the phenotypic differences between such rat strains," said Aitman.
Of the 788 mutated genes identified in the SHR genome, many are related to cellular functions such as ion transport and plasma membrane localization, as well as immunological and neurological processes. The authors suggest that defects in these functional categories may be causally associated with the known phenotypes of this strain.
Aitman explained that their characterization of genetic variation in the hypertensive rat would be invaluable for complete elucidation of the causes of hypertension and related traits at the molecular level in hypertensive rat. "This in turn will pave the way for greater understanding of the genetic basis of hypertension in humans," Aitman noted, "a problem that has proved remarkably difficult to study in humans directly."
Scientists from MRC Clinical Sciences Centre and Imperial College London (London, United Kingdom), the British Columbia Cancer Agency (Vancouver, Canada), the Hubrecht Institute (Utrecth, The Netherlands), the Max-Delbruck Center for Molecular Medicine (Berlin, Germany), the European Bioinformatics Institute (Hinxton, United Kingdom), the RIKEN Yokohama Institute (Yokohama, Japan), the RIKEN Brain Science Institute (Wako-shi, Japan), the University of California, San Francisco (San Francisco, CA), and the Academy of Sciences of the Czech Republic (Prague, Czech Republic) contributed to this study.
This work was supported by the Medical Research Council (UK), the Wellcome Trust (UK), the British Heart Foundation, the European Union, the Ministry of Education of the Czech Republic, the German Ministry for Science and Education, and the Netherlands Organization for Scientific Research.
About the article: The manuscript will be published online ahead of print on April 29, 2010. Its citation is as follows: Atanur SS, Birol I, Guryev V, Hirst M, Hummel O, Morrissey C, Behmoaras J, Fernadez-Suarez XM, Johnson MD, McLaren WM, et al. The genome sequence of the spontaneously hypertensive rat: Analysis and functional significance. Genome Res doi:10.1101/gr.103499.109.
On the Net: